Jennifer Byrne, CEO and founder, Javara, credits SCRS as a valuable part of the broader site landscape, pointing to its role ...

Sequoia’s Dan White and Dr. Tom Kreamer touch on why sponsors and CROs should treat a site network as one centralized ...

Kyle McAllister, co-founder and CEO, Trially, explains that under tight research preassure, the smaller, less visible tasks ...

Kyle McAllister, co-founder and CEO, Trially, identifies transparency as the defining characteristic of good AI-assisted ...

In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, explains why the shift from narrow AI tools to a continuous learning ...

In this Q&A, Saamir Pasha and Carole Berini, PhD, of Ontada discuss what it takes to harmonize fragmented oncology data into reliable real-world evidence, how lab markers can proxy for missing ...

Trially Co-founder and CEO Kyle McAllister, explains how AI absorbing the bulk of clinical-trial chart reviews can free research sites to focus staff time on higher-value tasks.

Register Free: https://www.appliedclinicaltrialsonline.com/act_w/Novel-Therapies ...

The FDA has announced the Rare Disease Framework Initiative, a broad effort to build a new regulatory approach tailored ...

The FDA has published a Transparency Roadmap outlining its fiscal year 2026 milestones and fiscal year 2027 priorities across ...

In today's ACT Brief, we examine how representation gaps in trials are shaped by structural design decisions, how new ...

IgniteData and RealTime eClinical Solutions have announced a partnership that will allow research sites using RealTime's ...